Aging Demographics And Precision Medicine Will Transform Global Oncology
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 19 Analysts
Published
18 May 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
US$57.81
33.5% undervalued intrinsic discount15 Aug
US$38.47
1Y
46.2%7D
2.9%